Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.

Abstract

This study evaluated an updated chemiluminescence enzyme immunoassay (CLEIA) for hepatitis C virus (HCV) core protein for monitoring viral kinetics during treatment with interferon (IFN)-alpha and ribavirin. Using the CLEIA, serum levels of HCV core protein were measured in 17 patients with genotype 1 and high baseline viral loads during the first 4 weeks… (More)

Topics

Cite this paper

@article{Enomoto2005ChemiluminescenceEI, title={Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.}, author={Masaru Enomoto and Shuhei Nishiguchi and A Tamori and Modoka Kohmoto and Daiki Habu and Hiroki Sakaguchi and Tadashi Takeda and Norifumi Kawada and Shuichi Seki and S. Shiomi}, journal={Journal of medical virology}, year={2005}, volume={77 1}, pages={77-82} }